Citations (43)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Ernesto Crisafulli, Andrea Zanini, Giovanna Pisi, Patrizia Pignatti, Gianluigi Poli, Mario Scuri & Alfredo Chetta. (2016) Inhaled beclometasone dipropionate/formoterol fumarate extrafine fixed combination for the treatment of asthma. Expert Review of Respiratory Medicine 10:5, pages 481-490.
Read now
Read now
Hiroshi Chantaphakul & Kiat Ruxrungtham. (2016) Fixed-Dose combination of the inhaled corticosteroid and long-acting beta2-agonist therapy in adults with persistent asthma. Expert Opinion on Pharmacotherapy 17:5, pages 631-642.
Read now
Read now
Nicola Scichilone, Alida Benfante, Luca Morandi, Federico Bellini & Alberto Papi. (2014) Impact of extrafine formulations of inhaled corticosteroids/long-acting beta-2 agonist combinations on patient-related outcomes in asthma and COPD. Patient Related Outcome Measures 5, pages 153-162.
Read now
Read now
Nicola Scichilone, Mario Spatafora, Salvatore Battaglia, Rita Arrigo, Alida Benfante & Vincenzo Bellia. (2013) Lung penetration and patient adherence considerations in the management of asthma: role of extra-fine formulations. Journal of Asthma and Allergy 6, pages 11-21.
Read now
Read now
Toby GD Capstick & Ian J Clifton. (2012) Inhaler technique and training in people with chronic obstructive pulmonary disease and asthma. Expert Review of Respiratory Medicine 6:1, pages 91-103.
Read now
Read now
Nicola Scichilone, Adele Contino, Giovanni Battista Figlioli, Giuseppe Paglino & Vincenzo Bellia. (2010) Patient perspectives in the management of asthma: improving patient outcomes through critical selection of treatment options. Patient Preference and Adherence 4, pages 17-23.
Read now
Read now
Gabriele Nicolini, Nicola Scichilone, Andrea Bizzi, Alberto Papi & Leonardo M Fabbri. (2008) Beclomethasone/formoterol fixed combination for the management of asthma: patient considerations. Therapeutics and Clinical Risk Management 4:5, pages 855-864.
Read now
Read now
Articles from other publishers (36)
Marcello Cottini, Benedetta Bondi, Diego Bagnasco, Fulvio Braido, Giovanni Passalacqua, Anita Licini, Carlo Lombardi, Alvise Berti, Pasquale Comberiati, Massimo Landi, Enrico Heffler & Giovanni Paoletti. (2023) Impulse oscillometry defined small airway dysfunction in asthmatic patients with normal spirometry: Prevalence, clinical associations, and impact on asthma control. Respiratory Medicine 218, pages 107391.
Crossref
Crossref
Luigino CALZETTA, Marina AIELLO, Annalisa FRIZZELLI, Giuseppina BERTORELLI & Alfredo CHETTA. (2022) Small airways in asthma: from bench-to-bedside. Minerva Medica 113:1.
Crossref
Crossref
Ting Liu, Dan Yang & Chuntao Liu. (2021) Extrafine HFA-beclomethasone-formoterol vs. nonextrafine combination of an inhaled corticosteroid and a long acting β2-agonist in patients with persistent asthma: A systematic review and meta-analysis. PLOS ONE 16:9, pages e0257075.
Crossref
Crossref
Petr Pohunek, Guido Varoli, Yuriy Reznichenko, Svetlana Mokia-Serbina, Jerzy Brzostek, Viktoriya Kostromina, Mykola Kaladze, Annamaria Muraro, Elena Carzana, Silvia Armani & Jadwiga Kaczmarek. (2021) Bronchodilating effects of a new beclometasone dipropionate plus formoterol fumarate formulation via pressurized metered-dose inhaler in asthmatic children: a double-blind, randomized, cross-over clinical study. European Journal of Pediatrics 180:5, pages 1467-1475.
Crossref
Crossref
Donald J. AbrahamJohn G. Montana, Hazel J. Dyke, J. Craig Fox & Nicholas C. Ray. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
1
47
.
Ashfaq Hasan, Priyanka Mukherjee, Sushmeeta Chhowala, Meena Lopez & PrashantN Chhajed. (2021) Small Airways, Big Problem: Extrafine beclomethasone/formoterol in asthma and chronic obstructive pulmonary disease. Lung India 38:4, pages 350.
Crossref
Crossref
I. N. Trofimenko & B. A. Chernyak. (2020) Extrafine combination beclomethasone dipropionate/ formoterol therapy in obstructive lung diseases. Meditsinskiy sovet = Medical Council:11, pages 108-115.
Crossref
Crossref
Marcello Cottini, Anita Licini, Carlo Lombardi & Alvise Berti. (2020) Clinical Characterization and Predictors of IOS-Defined Small-Airway Dysfunction in Asthma. The Journal of Allergy and Clinical Immunology: In Practice 8:3, pages 997-1004.e2.
Crossref
Crossref
Elisabetta Zinellu, Barbara Piras, Giulia G. M. Ruzittu, Sara S. Fois, Alessandro G. Fois & Pietro Pirina. (2019) Recent Advances in Inflammation and Treatment of Small Airways in Asthma. International Journal of Molecular Sciences 20:11, pages 2617.
Crossref
Crossref
I. V. Leshchenko & I. I. Baranova. (2019) Bronchial asthma: simple solutions of complex issues. Medical Council:6, pages 52-57.
Crossref
Crossref
Meng-Jer Hsieh, Yu-Ching Lin, Ruay-Sheng Lai, Chien-Liang Wu, Chun-Liang Lai, Chin-Chou Wang, Diahn-Warng Perng, Shang-Jyh Kao, En-Ting Chang, Hao-Chien Wang, Wann-Cherng Perng, Jeng-Yuan Hsu, Ching-Hsiung Lin & Ying-Huang Tsai. (2018) Comparative efficacy and tolerability of beclomethasone/formoterol and fluticasone/salmeterol fixed combination in Taiwanese asthmatic patients. Journal of the Formosan Medical Association 117:12, pages 1078-1085.
Crossref
Crossref
Samatha Sonnappa, Brett McQueen, Dirkje S. Postma, Richard J. Martin, Nicolas Roche, Jonathan Grigg, Theresa Guilbert, Caroline Gouder, Emilio Pizzichini, Akio Niimi, Wanda Phipatanakul, Alison Chisholm, Ronald J. Dandurand, Alan Kaplan, Elliot Israel, Alberto Papi, Willem M.C. van Aalderen, Omar S. Usmani & David B. Price. (2018) Extrafine Versus Fine Inhaled Corticosteroids in Relation to Asthma Control: A Systematic Review and Meta-Analysis of Observational Real-Life Studies. The Journal of Allergy and Clinical Immunology: In Practice 6:3, pages 907-915.e7.
Crossref
Crossref
Sohita Dhillon. (2017) Extrafine beclometasone dipropionate/formoterol fumarate metered-dose and dry-powder inhalers in asthma and chronic obstructive pulmonary disease: a profile of their use. Drugs & Therapy Perspectives 33:6, pages 260-271.
Crossref
Crossref
F. Braido, N. Scichilone, F. Lavorini, O. S. Usmani, L. Dubuske, L. P. Boulet, R. Mosges, C. Nunes, M. Sánchez-Borges, I. J. Ansotegui, M. Ebisawa, F. Levi-Schaffer, L. J Rosenwasser, J. Bousquet, T. Zuberbier & G. Walter Canonica. (2016) Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA2LEN). Asthma Research and Practice 2:1.
Crossref
Crossref
F. Braido, N. Scichilone, F. Lavorini, O.S. Usmani, L. Dubuske, L.P. Boulet, R. Mosges, C. Nunes, M. Sanchez-Borges, I.J. Ansotegui, M. Ebisawa, F. Levi-Schaffer, L.J. Rosenwasser, J. Bousquet, T. Zuberbier & G. Walter Canonica. (2016) Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA2LEN). World Allergy Organization Journal 9, pages 37.
Crossref
Crossref
Marcello Cottini, Carlo Lombardi & Claudio Micheletto. (2015) Small airway dysfunction and bronchial asthma control : the state of the art. Asthma Research and Practice 1:1.
Crossref
Crossref
Serpil BulacArif CimrinHulya Ellidokuz. (2015) The Effect of Beclometasone Dipropionate/Formoterol Extra-Fine Fixed Combination on the Peripheral Airway Inflammation in Controlled Asthma. Journal of Aerosol Medicine and Pulmonary Drug Delivery 28:2, pages 82-87.
Crossref
Crossref
Nicola Scichilone, Alida Benfante, Marialuisa Bocchino, Fulvio Braido, Pierluigi Paggiaro, Alberto Papi, Pierachille Santus & Alessandro Sanduzzi. (2015) Which factors affect the choice of the inhaler in chronic obstructive respiratory diseases?. Pulmonary Pharmacology & Therapeutics 31, pages 63-67.
Crossref
Crossref
Anne-Marie Kirsten, Henrik Watz, Caterina Brindicci, Annalisa Piccinno & Helgo Magnussen. (2015) Effects of beclomethason/formoterol and budesonide/formoterol fixed combinations on lung function and airway inflammation in patients with mild to moderate asthma – An exploratory study. Pulmonary Pharmacology & Therapeutics 31, pages 79-84.
Crossref
Crossref
Nicola Scichilone. (2015) Asthma Control: The Right Inhaler for the Right Patient. Advances in Therapy 32:4, pages 285-292.
Crossref
Crossref
Neil Barnes, Jan Arie van Noord, Caterina Brindicci, Ludger Lindemann, Guido Varoli, Miguel Perpiña, Daniele Guastalla, Daniela Casula, Shishir Patel & Pascal Chanez. (2013) Stepping-across controlled asthmatic patients to extrafine beclometasone/formoterol combination. Pulmonary Pharmacology & Therapeutics 26:5, pages 555-561.
Crossref
Crossref
Nicola Scichilone, Marco Contoli, Davide Paleari, Pietro Pirina, Andrea Rossi, Claudio Maria Sanguinetti, Pierachille Santus, Matteo Sofia & Nicola Sverzellati. (2013) Assessing and accessing the small airways; implications for asthma management. Pulmonary Pharmacology & Therapeutics 26:2, pages 172-179.
Crossref
Crossref
Kwang Ha Yoo. (2013) Inhalation medications in chronic airway disease. Journal of the Korean Medical Association 56:7, pages 625.
Crossref
Crossref
R S Fassakhov. (2012) SEVERE ASTHMA: PHENOTYPES AND ROLE OF SMALL AIRWAYS. Russian Journal of Allergy 9:6, pages 49-54.
Crossref
Crossref
Dave Singh, Massimo Corradi, Eddi Bindi, Roberta Baronio, Stefano Petruzzelli & Pierluigi Paggiaro. (2012) Relief of methacholine-induced bronchospasm with extrafine beclomethasone dipropionate/formoterol in comparison with salbutamol in asthma. Pulmonary Pharmacology & Therapeutics 25:5, pages 392-398.
Crossref
Crossref
Luigi Allegra, Giovanni Cremonesi, Giuseppe Girbino, Eleonora Ingrassia, Serafino Marsico, Gabriele Nicolini & Claudio Terzano. (2012) Real-life prospective study on asthma control in Italy: Cross-sectional phase results. Respiratory Medicine 106:2, pages 205-214.
Crossref
Crossref
Alberto Papi, Gabriele Nicolini, Nunzio Crimi, Leonardo Fabbri, Dario Olivieri, Andrea Rossi & Pierluigi Paggiaro. (2012) Step-down from high dose fixed combination therapy in asthma patients: a randomized controlled trial. Respiratory Research 13:1, pages 54.
Crossref
Crossref
Brian J O'Connor, Sara Collarini, Gianluigi Poli, Caterina Brindicci, Monica Spinola, Daniela Acerbi, Peter J Barnes & Brian Leaker. (2011) Rapid effects of extrafine beclomethasone dipropionate/formoterol fixed combination inhaler on airway inflammation and bronchoconstriction in asthma: a randomised controlled trial. BMC Pulmonary Medicine 11:1.
Crossref
Crossref
Veronika Müller, Gabriella Gálffy, Noemi Eszes, György Losonczy, Andrea Bizzi, Gabriele Nicolini, Henry Chrystyn & Lilla Tamási. (2011) Asthma control in patients receiving inhaled corticosteroid and long-acting beta2-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation. BMC Pulmonary Medicine 11:1.
Crossref
Crossref
P.M.A. Calverley, P. Kuna, E. Monsó, M. Costantini, S. Petruzzelli, F. Sergio, G. Varoli, A. Papi & V. Brusasco. (2010) Beclomethasone/formoterol in the management of COPD: A randomised controlled trial. Respiratory Medicine 104:12, pages 1858-1868.
Crossref
Crossref
N. Scichilone, S. Battaglia, C. Sorino, G. Paglino, L. Martino, A. Paternò, R. Santagata, M. Spatafora, G. Nicolini & V. Bellia. (2010) Effects of extra‐fine inhaled beclomethasone/formoterol on both large and small airways in asthma. Allergy 65:7, pages 897-902.
Crossref
Crossref
Wilfried De BackerAnnick DevolderGianluigi PoliDaniela AcerbiRaffaella MonnoChristiane HerpichKnut SommererThomas MeyerFabrizia Mariotti. (2010) Lung Deposition of BDP/Formoterol HFA pMDI in Healthy Volunteers, Asthmatic, and COPD Patients. Journal of Aerosol Medicine and Pulmonary Drug Delivery 23:3, pages 137-148.
Crossref
Crossref
Donald J. AbrahamJohn G. Montana, Hazel J. Dyke, J. Craig Fox & Nicholas C. Ray. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
747
790
.
Klaus J. Erb, Domnic H. Martyres & Peter Seither. 2003. Ullmann's Encyclopedia of Industrial Chemistry. Ullmann's Encyclopedia of Industrial Chemistry.
N M Nenasheva & N M Nenasheva. (2009) NEW FIXED COMBINATION (FOSTER) FOR LONG AND SAFE ASTHMA CONTROL. Russian Journal of Allergy 6:6, pages 68-74.
Crossref
Crossref
C. Lazzaro, P. Ruffo & M. Gozzo. (2013) Analisi costo-efficacia dell’associazione budesonide/formoterolo come terapia di mantenimento e “al bisogno” nella gestione dell’asma. Valutazione italianaCost-effectiveness analysis of budesonide/formoterol combination for both maintenance and reliever therapy in the management of asthma. An Italian evaluation. PharmacoEconomics Italian Research Articles 11:1, pages 39-53.
Crossref
Crossref